Trial Profile
Treatment of Advanced Colorectal Cancer Patients With Hepatic Liver Metastases Using the CCR5-Antagonist Maraviroc (Phase I Maracon Trial)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Adverse reactions
- Acronyms MARACON
- 07 Jan 2013 New trial record